Osaka, Japan

Yasushi Sanno


Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 51(Granted Patents)


Location History:

  • Osaka, JA (1976 - 1978)
  • Ikeda, JA (1976 - 1978)
  • Osaka, JP (1978 - 1979)

Company Filing History:


Years Active: 1976-1979

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yasushi Sanno

Introduction

Yasushi Sanno is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of 12 patents to his name, Sanno's work has had a considerable impact on the development of new therapeutic agents.

Latest Patents

Among his latest patents, Sanno has developed novel N-benzylpiperazine derivatives. These compounds exhibit respiratory tract fluid secretion stimulatory properties and are useful as medicines for respiratory conditions. Additionally, he has created novel chromone derivatives that serve as intermediates for chromones with effective anti-allergic action. These advancements highlight his commitment to addressing medical needs through innovative chemical solutions.

Career Highlights

Sanno is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to collaborate with other talented researchers and contribute to the development of new medications. His dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Throughout his career, Yasushi Sanno has worked alongside esteemed colleagues such as Hirosada Sugihara and Akira Nohara. These collaborations have fostered a productive environment for innovation and have led to the successful development of various pharmaceutical compounds.

Conclusion

Yasushi Sanno's contributions to medicinal chemistry through his patents and collaborations underscore his role as an influential inventor. His work continues to pave the way for advancements in therapeutic agents, benefiting the medical community and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…